TrialPanorama/TrialPanorama-database huggingface dataset:
Study 32518064 — Predictive Biomarker (PRD): HNF1A mRNA
Genes: HNF1A; TCF1
Study 34583626 — Predictive Biomarker (PRD): OSR1 mRNA
Genes: OSR1; ODD
Study 36374508 — Predictive Biomarker (PRD): ACSM1 mRNA
Genes: ACSM1; BUCS1; LAE; MACS1
Study 34000112 — Surrogate Endpoint (SUR): Blood pressure
Study 34000112 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 34391588 — Predictive Biomarker (PRD): FTCD mRNA
Genes: FTCD
Study 34391588 — Surrogate Endpoint (SUR): Exhaled carbon monoxide
Study 33967022 — Predictive Biomarker (PRD): SDS mRNA
Genes: SDS; SDH
Study 34487441 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study 32870155 — Predictive Biomarker (PRD): LCT mRNA
Genes: LCT; LPH
Study 35403393 — Predictive Biomarker (PRD): REM1 mRNA
Genes: REM1; GES; REM
Study 33430665 — Predictive Biomarker (PRD): Liver iron
Study 34578782 — Predictive Biomarker (PRD): VDR mRNA
Genes: VDR; NR1I1
Study 33248625 — Surrogate Endpoint (SUR): Bone mineral density
Study 33662625 — Predictive Biomarker (PRD): CCS mRNA
Genes: CCS
Study 32678716 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 35902652 — Surrogate Endpoint (SUR): Blood pressure
Study 35902652 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 35902652 — Surrogate Endpoint (SUR): Serum creatinine
Study 34158069 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 34275096 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33818302 — Predictive Biomarker (PRD): PGD mRNA
Genes: PGD; PGDH
Study 34393122 — Predictive Biomarker (PRD): Vitamin D-binding protein
Genes: GC
Study 33333521 — Predictive Biomarker (PRD): MIP mRNA
Genes: MIP; AQP0
Study 32147436 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study 34799219 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 34799219 — Safety Biomarker (SAF): IL-6 and IL-10
Study 34033974 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 34033974 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 34033974 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 34033974 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 34048943 — Predictive Biomarker (PRD): BPI mRNA
Genes: BPI
Study 32772019 — Surrogate Endpoint (SUR): Blood pressure
Study 35314069 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study 33027073 — Predictive Biomarker (PRD): PLAG1 mRNA
Genes: PLAG1
Study 33027073 — Predictive Biomarker (PRD): LIFR mRNA
Genes: LIFR
Study 33027073 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CTNNB1 mRNA
Genes: CTNNB1; CTNNB; OK/SW-cl.35; PRO2286
Study 33027073 — Predictive Biomarker (PRD): CHCHD7 mRNA
Genes: CHCHD7
Study 33027073 — Predictive Biomarker (PRD): ATF1 mRNA
Genes: ATF1
Study 33027073 — Predictive Biomarker (PRD): FGFR1 mRNA
Genes: FGFR1; BFGFR; CEK; FGFBR; FLG; FLT2; HBGFR
Study 33147705 — Predictive Biomarker (PRD); Safety Biomarker (SAF): miR-122
Genes: MIR122
Study 32387716 — Surrogate Endpoint (SUR): Blood pressure
Study 34274514 — Predictive Biomarker (PRD): OCA2 mRNA
Genes: OCA2; D15S12; P
Study 33085857 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 33645243 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 33645243 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 33645243 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study 33645243 — Predictive Biomarker (PRD): Hormone receptor
Study 35682213 — Surrogate Endpoint (SUR): Blood pressure
Study 34009274 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 34009274 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 34009274 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 34009274 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34009274 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Interleukin 6 receptor alpha
Genes: IL6R
Study 36396331 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study 36396331 — Surrogate Endpoint (SUR): Serum sodium
Study 34540787 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 34002560 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33053116 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 35818254 — Safety Biomarker (SAF): IL-6 and IL-10
Study 36370907 — Predictive Biomarker (PRD): JAK3 mRNA
Genes: JAK3
Study 33579240 — Surrogate Endpoint (SUR): Blood pressure
Study 32315810 — Monitoring Biomarker (MOI): HBV DNA
Study 33579265 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 33579265 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 33579265 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study 33579265 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Interleukin 17
Genes: IL17A; CTLA8; IL17
Study 34254406 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 36403804 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 36403804 — Surrogate Endpoint (SUR): Blood pressure
Study 32747190 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 33938672 — Surrogate Endpoint (SUR): Blood pressure
Study 34621519 — Surrogate Endpoint (SUR): Serum creatinine
Study 32158190 — Surrogate Endpoint (SUR): Blood pressure
Study 35743790 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study 35743790 — Predictive Biomarker (PRD): HTR2A mRNA
Genes: HTR2A; HTR2
Study 35743790 — Predictive Biomarker (PRD): 5HTT
Genes: SLC6A4; 5-HTT; SERT1
Study 33319386 — Surrogate Endpoint (SUR): Blood pressure
Study 33674871 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 34033648 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34033648 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 34097649 — Surrogate Endpoint (SUR): Blood pressure
Study 33652088 — Surrogate Endpoint (SUR): Blood pressure
Study 35685535 — Surrogate Endpoint (SUR): Serum alkaline phosphatase
Study 35475592 — Predictive Biomarker (PRD): Ki-67
Genes: MKI67; MIB-1; PPP1R105
Study 35475592 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 34320702 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 34320702 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 34320702 — Predictive Biomarker (PRD): IL6
Genes: IL-6; BSF2; HGF; HSF
Study 34320702 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study 32928709 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study 32928709 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 32088665 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study 34688917 — Predictive Biomarker (PRD): PPARA mRNA
Genes: PPARA; NR1C1; PPAR
Study 33394894 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 33921792 — Predictive Biomarker (PRD): COG2 mRNA
Genes: COG2; LDLC
Study 33921792 — Surrogate Endpoint (SUR): Blood pressure
Study 33921792 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 34629245 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32871870 — Monitoring Biomarker (MOI): Tissue transglutaminase
Genes: TGM2
Study 35869988 — Predictive Biomarker (PRD): PNP mRNA
Genes: PNP; NP
Study 34969409 — Predictive Biomarker (PRD): TSPAN31 mRNA
Genes: TSPAN31; SAS
Study 34969409 — Predictive Biomarker (PRD): SDS mRNA
Genes: SDS; SDH
Study 35438091 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study 33971153 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Interleukin 17
Genes: IL17A; CTLA8; IL17
Study 36134918 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 34526079 — Predictive Biomarker (PRD): SDS mRNA
Genes: SDS; SDH
Study 32214138 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 33509804 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study 33280441 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 33280441 — Predictive Biomarker (PRD): LITAF mRNA
Genes: LITAF; PIG7; SIMPLE
Study 33280441 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Complement C3
Genes: C3; CPAMD1
Study 35132659 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 33982280 — Predictive Biomarker (PRD); Safety Biomarker (SAF): STAR mRNA
Genes: STAR; STARD1
Study 32301894 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 32301894 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 32858717 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 34474649 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 36304565 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study 35007129 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34733454 — Surrogate Endpoint (SUR): Serum potassium
Study 32984892 — Predictive Biomarker (PRD): ACE2 mRNA
Genes: ACE2; UNQ868/PRO1885
Study 32984892 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 32984892 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32984892 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 32984892 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 32984892 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study 32114502 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study 32151708 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 32385647 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study 32298853 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study 36410828 — Predictive Biomarker (PRD): Hormone receptor
Study 33326172 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study 33326172 — Surrogate Endpoint (SUR): Blood pressure
Study 33308131 — Predictive Biomarker (PRD): ACAD8 mRNA
Genes: ACAD8; ARC42; IBD
Study 32224233 — Predictive Biomarker (PRD): CD46 mRNA
Genes: CD46; MCP; MIC10
Study 34397689 — Predictive Biomarker (PRD): RALA mRNA
Genes: RALA; RAL
Study 34397689 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 35045564 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33844928 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 32828845 — Predictive Biomarker (PRD): BBOX1 mRNA
Genes: BBOX1; BBH; BBOX
Study 33798455 — Surrogate Endpoint (SUR): Forced vital capacity
Study 32541171 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 36082248 — Predictive Biomarker (PRD): CCR5 mRNA
Genes: CCR5; CMKBR5
Study 32513299 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 34185066 — Surrogate Endpoint (SUR): Blood pressure
Study 34369695 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study 34369695 — Surrogate Endpoint (SUR): Forced vital capacity
Study 34015765 — Surrogate Endpoint (SUR): Bone mineral density
Study 35616251 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 32750916 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 34034702 — Predictive Biomarker (PRD): GRK5 mRNA
Genes: GRK5; GPRK5
Study 34034702 — Pharmacodynamic Biomarker (PDY): Matrix metalloproteinase 9
Genes: MMP9; CLG4B
Study 34034702 — Predictive Biomarker (PRD): MED12L mRNA
Genes: MED12L; KIAA1635; TNRC11L; TRALP; TRALPUSH; PRO0314
Study 35757330 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 35757330 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study 33188136 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 33996266 — Predictive Biomarker (PRD): CXCL13 mRNA
Genes: CXCL13; BCA1; BLC; SCYB13
Study 32928255 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Growth/differentiation factor 15
Genes: GDF15; MIC1; PDF; PLAB; PTGFB
Study 33106167 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 33106167 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33106167 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 33106167 — Surrogate Endpoint (SUR): Serum creatinine
Study 34302120 — Surrogate Endpoint (SUR): Blood pressure
Study 32698618 — Safety Biomarker (SAF): RFC1
Genes: A1; PO-GA; RFC140; MHCBFB
Study 35966074 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study 36177637 — Surrogate Endpoint (SUR): Bone mineral density
Study 34332453 — Surrogate Endpoint (SUR): Forced vital capacity
Study 34789188 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 35904836 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 35904836 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 32026826 — Safety Biomarker (SAF): Hyaluronic acid
Study 34543687 — Surrogate Endpoint (SUR): Blood pressure
Study 32658621 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 33118206 — Predictive Biomarker (PRD): TPR mRNA
Genes: TPR
Study 32911375 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 33197560 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study 34503491 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Complement C3
Genes: C3; CPAMD1
Study 33251670 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 33251670 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 33479268 — Predictive Biomarker (PRD): ROS1
Genes: MCF3; ROS; c-ros-1
Study 33479268 — Safety Biomarker (SAF): Reactive oxygen species
Study 34462956 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34462956 — Safety Biomarker (SAF): Neutrophil to lymphocyte
Study 35793409 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 35793409 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 36127866 — Predictive Biomarker (PRD): KL mRNA
Genes: KL
Study 32464807 — Predictive Biomarker (PRD): PGD mRNA
Genes: PGD; PGDH
Study 32464807 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 34570990 — Surrogate Endpoint (SUR): Blood pressure
Study 33096554 — Surrogate Endpoint (SUR): Blood pressure
Study 32186014 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 32186014 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 33840769 — Surrogate Endpoint (SUR): Blood pressure
Study 35346044 — Predictive Biomarker (PRD): COMT mRNA
Genes: COMT
Study 32520602 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 32900785 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study 34821437 — Surrogate Endpoint (SUR): Blood pressure
Study 32101157 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32101157 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 35705671 — Surrogate Endpoint (SUR): Blood pressure
Study 33822134 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 33822134 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 34799534 — Predictive Biomarker (PRD): NTS mRNA
Genes: NTS
Study 35063963 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 33670999 — Surrogate Endpoint (SUR): Blood pressure
Study 34726747 — Surrogate Endpoint (SUR): Blood pressure
Study 34726747 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 35796669 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study 33935094 — Predictive Biomarker (PRD): PON1 mRNA
Genes: PON1; PON
Study 33935094 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study 33935094 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study 34971816 — Surrogate Endpoint (SUR): Blood pressure
Study 35896694 — Surrogate Endpoint (SUR): Bone mineral density
Study 36197699 — Predictive Biomarker (PRD): PVR mRNA
Genes: PVR; PVS
Study 32193269 — Predictive Biomarker (PRD): BPI mRNA
Genes: BPI
Study 32745170 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study 34979421 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 32219761 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 32219761 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 35715803 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 35715803 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 33183970 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 33183970 — Predictive Biomarker (PRD): Hormone receptor
Study 32108355 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study 33346375 — Surrogate Endpoint (SUR): Blood pressure
Study 33346375 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 35978350 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 35978350 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 32157334 — Surrogate Endpoint (SUR): Bone mineral density
Study 33167735 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 34155966 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study 35641211 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study 35456180 — Surrogate Endpoint (SUR): Blood pressure
Study 34749668 — Surrogate Endpoint (SUR): Blood pressure
Study 34427115 — Predictive Biomarker (PRD): Microsatellite instability
Study 32616238 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 34106630 — Predictive Biomarker (PRD): CRH mRNA
Genes: CRH
Study 36281683 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study 33223374 — Predictive Biomarker (PRD): ABO mRNA
Genes: ABO
Study 33036661 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study 35239009 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 32348166 — Predictive Biomarker (PRD): ACE2 mRNA
Genes: ACE2; UNQ868/PRO1885
Study 32348166 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32348166 — Monitoring Biomarker (MOI): Procalcitonin
Study 32348166 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 32348166 — Surrogate Endpoint (SUR): Blood pressure
Study 32807165 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 32807165 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 36293555 — Predictive Biomarker (PRD): TLR4 mRNA
Genes: TLR4
Study 36293555 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study 33113155 — Predictive Biomarker (PRD): S100A12 mRNA
Genes: S100A12
Study 33113155 — Predictive Biomarker (PRD): CDHR1 mRNA
Genes: CDHR1; KIAA1775; PCDH21; PRCAD
Study 33334933 — Predictive Biomarker (PRD): AGER mRNA
Genes: AGER; RAGE
Study 34998371 — Surrogate Endpoint (SUR): Blood pressure
Study 33298663 — Surrogate Endpoint (SUR): Blood pressure
Study 34133087 — Predictive Biomarker (PRD); Safety Biomarker (SAF): SLC6A4 mRNA
Genes: SLC6A4; HTT; SERT
Study 36150304 — Predictive Biomarker (PRD): FOS mRNA
Genes: FOS; G0S7
Study 33545972 — Surrogate Endpoint (SUR): Blood pressure
Study 35073398 — Predictive Biomarker (PRD): Forkhead box protein P3
Genes: FOXP3; IPEX; JM2
Study 35073398 — Safety Biomarker (SAF): HLA-DRB1
Genes: HLA-DR1B
Study 33618181 — Predictive Biomarker (PRD): LPCAT1 mRNA
Genes: LPCAT1; AYTL2; PFAAP3
Study 33441099 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study 34239940 — Surrogate Endpoint (SUR): Serum uric acid
Study 32932868 — Surrogate Endpoint (SUR): Blood pressure
Study 35812198 — Predictive Biomarker (PRD): PVR mRNA
Genes: PVR; PVS
Study 35995769 — Predictive Biomarker (PRD): RARA mRNA
Genes: RARA; NR1B1
Study 35995769 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 35995769 — Predictive Biomarker (PRD): AADAC mRNA
Genes: AADAC; DAC